Prosecutors raid Korean Exchange in BioLogics probeProsecutors raided Korea’s main stock exchange Friday during an investigation into Samsung BioLogics’ alleged accounting fraud.
Investigators from the Seoul Central District Prosecutors’ Office searched the Korean Exchange (KRX) in western Seoul. Investigators suspect that KRX intentionally erased the initial public offering (IPO) rules to make BioLogics eligible for listing on the Kospi market.
The biopharmaceutical company is being investigated for breaking accounting rules to inflate the value of its subsidiary, Samsung Bioepis, ahead of BioLogics’ IPO in 2016. The Financial Services Commission reported that the alleged fraudulent accounting could amount to 4.5 trillion won ($3.96 billion).
By Ko Jun-tae
More in Industry
Eastar Jet's pilot union pushes for receivership of airline
ITC agrees to review its decision in Botox dispute
Hyundai Motor and union come to a wage freeze deal
Samsung Biologics signs supply deal with AstraZeneca
Tesla to increase battery cell purchases from suppliers including LG